O'Byrne Jason sold VIR
November 17, 2025 · Form 4 insider transaction
O'Byrne Jason sold 6,799 shares of Vir Biotechnology, Inc. at $5.56 per share, a transaction worth $37.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
6,799
Price
$5.56
Total value
$37.8K
InsiderO'Byrne Jason
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 17, 2025
Filing dateNovember 18, 2025
Shares owned after110,701
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.; Includes 2,500 shares of common stock acquired by the Reporting Person on May 30, 2025 pursuant to an employee stock purchase program.